Membrane Proteins: Pain or gain?

The 3D structures of a membrane protein called TMEM120A suggest that it may act as an enzyme in fat metabolism rather than as an ion channel that senses mechanical pain.
  1. Valeria Kalienkova  Is a corresponding author
  1. University of Groningen, Netherlands

All cells are surrounded by a lipid membrane that is not permeable to ions and other solutes. To enter or leave a cell, therefore, ions and solutes must pass through proteins that are embedded in the lipid membrane. This gatekeeping role means that transmembrane proteins are involved in a number of physiological processes, and if they fail to work properly, the result can be a severe metabolic defect.

Membrane proteins belonging to the TMEM120 family have been associated with a wide variety of functions, and recently it was reported that one family member – TMEM120A (also referred to as TACAN) – was highly expressed in clusters of neurons called dorsal root ganglia, and was involved in the sensing of mechanical pain (Beaulieu-Laroche et al., 2020). This study suggested that TMEM120A was a channel protein that, when activated by a mechanical stimulus, allowed positive ions to cross the lipid membrane by passing through a pore within the protein. Now, in eLife, Zhenfeng Liu, Bailong Xiao, Yan Zhao and colleagues at the Chinese Academy of Sciences and Tsinghua University report the results of a series of cryo-electron microscopy and electrophysiology experiments that reveal new details about this protein and call its role in the detection of mechanical pain into question (Rong et al., 2021).

First, the researchers – who include Yao Rong, Jinghui Jiang and Jianli Guo as joint first authors – used cryo-electron microscopy to determine the three-dimensional structure of TMEM120A. This revealed a rather novel architecture: the protein is made up of two monomers, both of which contain six segments that have a helical shape (Figure 1). It is possible that ions can pass through a channel formed by the six transmembrane helices in each monomer. However, the 3D structure also revealed the presence of a molecule bound to the inside of the putative channel that would prevent the passage of ions through it. Rong et al. hypothesized that this molecule was an endogenous ligand that had remained tightly bound to the protein when it was being purified prior to the cryo-electron microscopy experiments, and then used mass spectrometry to show that the molecule was coenzyme A (CoASH). This coenzyme is primarily known for helping to synthesize and degrade various cellular compounds, including fatty acids (Gout, 2018), and it had not previously been associated with mechanosensation.

The structure of the membrane protein TMEM120A.

Schematic showing the structures of the membrane-embedded region of the protein TMEM120A. This region of the protein is comprised of two monomers, both of which contain six helical segments (blue cylinders) that span across the lipid bilayer (pale yellow and gray). When a coenzyme called CoASH (yellow) is present, it binds to a site inside the helical segments (left). When CoASH is not present (right), two of the cytoplasmic loops (orange) that connect helical segments change their position to cover the entrance to the binding site. Cytoplasmic loops that do not change their position are not shown.

To investigate this further, Rong et al. purified TMEM120A without the coenzyme and determined its 3D structure. The two structures were similar, apart from the shape of two cytoplasmic loops: in the CoASH-bound state the loops extended into the cytoplasm of the cell; however, when CoASH was not present the loops partially closed the entrance to the channel in each monomer (Figure 1). Rong et al. then used these structures to identify which amino acid residues are involved in the binding of CoASH. Further experiments showed that mutating one of these residues, a conserved tryptophan, dramatically decreased the affinity of TMEM120A for CoASH.

By conclusively showing that TMEM120A specifically interacts with CoASH, the work of Rong et al. suggests that this membrane protein might in fact work as a membrane-embedded enzyme. It is also notable that Rong et al., along with several other groups (Ke et al., 2021; Niu et al., 2021; Parpaite et al., 2021; Rong et al., 2021; Xue et al., 2021), could not reproduce the mechanosensitive currents reported previously. Moreover, there are several lines of evidence to suggest that TMEM120A has a greater role in lipid metabolism. Originally, TMEM120A was shown to be important for fat tissue differentiation (Batrakou et al., 2015). Several recent reports have shown that C. elegans and mammalian cells need it to accumulate fat, and that disrupting the gene for TMEM120A leads to metabolic defects in mice fed a high-fat diet (Czapiewski et al., 2021; Li et al., 2021). In addition, its structure also resembles that of ELOVL7, a membrane-embedded enzyme that helps to elongate fatty acids (Nie et al., 2020; Niu et al., 2021; Xue et al., 2021). However, TMEM120A does not catalyze the same reactions as ELOVL7, and the possible substrates and end products of TMEM120A remain unknown (Niu et al., 2021).

These findings do not completely rule out a role for TMEM120A as a mechanosensitive channel. Computational modeling suggests that it might be able to act as an ion channel in the absence of CoASH (Chen et al., 2021). Alternatively, the addition of extra subunits may be required for it to work as an ion channel (Chen et al., 2021). Furthermore, TMEM120A may contribute to mechanosensation by modulating other mechanosensitive channels in dorsal root ganglia (Del Rosario et al., 2021). Undoubtedly, the work by Rong et al. provides new insights into proteins belonging to the TMEM120 family, and the controversy surrounding their role will likely fuel future scientific endeavors.


Article and author information

Author details

  1. Valeria Kalienkova

    Valeria Kalienkova is at the University of Groningen, Groningen, Netherlands

    For correspondence
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4143-6172

Publication history

  1. Version of Record published: September 29, 2021 (version 1)


© 2021, Kalienkova

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 1,300
    Page views
  • 86
  • 0

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Valeria Kalienkova
Membrane Proteins: Pain or gain?
eLife 10:e73378.

Further reading

    1. Computational and Systems Biology
    2. Neuroscience
    Hossein Shahabi, Dileep R Nair, Richard M Leahy
    Research Article Updated

    Seizure generation, propagation, and termination occur through spatiotemporal brain networks. In this paper, we demonstrate the significance of large-scale brain interactions in high-frequency (80–200Hz) for the identification of the epileptogenic zone (EZ) and seizure evolution. To incorporate the continuity of neural dynamics, here we have modeled brain connectivity constructed from stereoelectroencephalography (SEEG) data during seizures using multilayer networks. After introducing a new measure of brain connectivity for temporal networks, named multilayer eigenvector centrality (mlEVC), we applied a consensus hierarchical clustering on the developed model to identify the EZ as a cluster of nodes with distinctive brain connectivity in the ictal period. Our algorithm could successfully predict electrodes inside the resected volume as EZ for 88% of participants, who all were seizure-free for at least 12 months after surgery. Our findings illustrated significant and unique desynchronization between EZ and the rest of the brain in the early to mid-seizure. We showed that aging and the duration of epilepsy intensify this desynchronization, which can be the outcome of abnormal neuroplasticity. Additionally, we illustrated that seizures evolve with various network topologies, confirming the existence of different epileptogenic networks in each patient. Our findings suggest not only the importance of early intervention in epilepsy but possible factors that correlate with disease severity. Moreover, by analyzing the propagation patterns of different seizures, we demonstrate the necessity of collecting sufficient data for identifying epileptogenic networks.

    1. Neuroscience
    Yonatan Sanz Perl, Sol Fittipaldi ... Enzo Tagliazucchi
    Research Article

    The treatment of neurodegenerative diseases is hindered by lack of interventions capable of steering multimodal whole-brain dynamics towards patterns indicative of preserved brain health. To address this problem, we combined deep learning with a model capable of reproducing whole-brain functional connectivity in patients diagnosed with Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD). These models included disease-specific atrophy maps as priors to modulate local parameters, revealing increased stability of hippocampal and insular dynamics as signatures of brain atrophy in AD and bvFTD, respectively. Using variational autoencoders, we visualized different pathologies and their severity as the evolution of trajectories in a low-dimensional latent space. Finally, we perturbed the model to reveal key AD- and bvFTD-specific regions to induce transitions from pathological to healthy brain states. Overall, we obtained novel insights on disease progression and control by means of external stimulation, while identifying dynamical mechanisms that underlie functional alterations in neurodegeneration.